Case Report
Published on 27 Aug 2024
A rare case of myxoma mimicking pulmonary thromboembolism: a case report
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1433381
- 1,111 views
Type at least 3 characters
363 articles
Review
Published on 26 Jul 2024
Bruton tyrosine kinase inhibitor-related atrial fibrillation and its implications in the treatment of B-cell lymphoma
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1408983
- 2,589 views
Review
Published on 11 Jul 2024
Anticancer drugs and cardiotoxicity: the role of cardiomyocyte and non-cardiomyocyte cells
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1372817
- 9,325 views
- 5 citations
Case Report
Published on 25 Jun 2024
Recurrence of an undifferentiated pleomorphic pulmonary artery sarcoma 8 years after initial presentation: a case report
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1378333
- 1,163 views
Original Research
Published on 14 Jun 2024
Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1347547
- 2,608 views
Case Report
Published on 13 Jun 2024
Case Report: Primary malignant mesothelioma of the left atrium easily misdiagnosed as myxoma
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1398311
- 2,035 views
- 1 citation
Case Report
Published on 07 Jun 2024
Atrioventricular re-entrant tachycardia and atrioventricular node re-entrant tachycardia in a patient with cancer under chemotherapy: a case report and literature review
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1367893
- 1,909 views
- 2 citations
Case Report
Published on 17 May 2024
Case Report: Assessment of primary myxofibrosarcoma in the left atrium using multimodal ultrasonography
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1378655
- 1,182 views
- 1 citation
Original Research
Published on 16 May 2024
Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1289663
- 7,190 views
- 14 citations
Original Research
Published on 25 Apr 2024
Thyroid cancer and cardiovascular diseases: a Mendelian randomization study
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1344515
- 3,540 views
- 3 citations
Original Research
Published on 04 Apr 2024
Prevalence and outcomes of atrial fibrillation in patients suffering prostate cancer: a national analysis in the United States
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1382166
- 2,569 views
- 1 citation
Case Report
Published on 22 Mar 2024
Case Report: Two cases of advanced primary cardiac angiosarcoma treated with anlotinib and a retrospective analysis of the literature
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1363235
- 1,979 views
- 1 citation
Original Research
Published on 21 Mar 2024
Exploring the effects of calycosin on anthracycline-induced cardiotoxicity: a network pharmacology, molecular docking, and experimental study
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1286620
- 3,086 views
- 3 citations
Editorial
Published on 06 Mar 2024
Editorial: Interpretable predictive analytics for precision cardio-oncology preventive care
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1377749
- 1,570 views
Case Report
Published on 29 Feb 2024
Navigating P2Y12 inhibition in the labyrinth of cardio-oncology care: cangrelor bridging in patients with cancer
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1337957
- 2,404 views
- 1 citation
Case Report
Published on 28 Feb 2024
Case Report: A case of third-degree atrioventricular block associated with primary cardiac lymphoma
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1356134
- 2,015 views